Background Image
Table of Contents Table of Contents
Previous Page  15 / 772 Next Page
Information
Show Menu
Previous Page 15 / 772 Next Page
Page Background

13

Morningstar FundInvestor

January 2

015

Leaders

T. Rowe Price Capital Appreciation

PRWCX

This fund has outperformed at least

87%

of its

moderate-allocation peers in each of the past six

calendar years. Winners in

2014

included

Allergan

AGN

, which nearly doubled in value during the

year,

PG&E

PCG

, and

UnitedHealth Group

UNH

.

The fixed-income portfolio, which takes about

25%

of assets, also did well. Lead manager David Giroux

had avoided Treasuries for years but bought some

at the end of

2013

and sold that stake down in

2014

as it rallied. Meanwhile, a

9%

cash allocation

weighed on results.

Western Asset Core Plus Bond

WACPX

Western Asset Core Plus Bond’s

7

.

7%

return in

2014

outpaced

97%

of its intermediate-term bond com-

petitors’ and easily topped the Barclays U.S. Aggre-

gate Bond Index’s

6%

gain. A contrarian bet to

increase duration exposure at the start of the year

boosted results. Stakes in nonagency mortgage

securities and investment-grade corporate bonds also

helped returns though most of the year. The fund

had a poor showing in

2008

, but the management

team made a number of improvements to its invest-

ment process, and the fund has outperformed its

typical competitor in every calendar year since

2009

.

Fidelity Growth Company

FDGRX

This fund has finished in the top quartile of its

large-growth peer group in each calendar year since

2009

. Longtime lead manager Steve Wymer favors

companies in fast-growing industries with distinctive

products, which has led to a heavy allocation to

the health-care sector. Biotech, which currently takes

16%

of assets, has played a huge role in the fund’s

outperformance over the past three years. A position

in

Keurig Green Mountain

GMCR

and airline picks

also propelled returns in

2014

.

Laggards

Buffalo Small Cap

BUFSX

Buffalo Small Cap’s

6

.

6%

loss in

2014

puts it in the

small-growth category’s bottom decile. A couple

of stocks halved in value, and many others suffered

double-digit losses. Several of the fund’s worst

performers during the year were among the biggest

gainers in

2012

and

2013

, such as

Financial Engines

FNGN

and

Chart Industries

GTLS

. While the

managers have trimmed some of those positions, for

the most part they’ve held tight.

American Funds New Economy

ANEFX

This fund’s

4

.

6%

return in

2014

was a decent absolute

showing, though its typical large-growth rival gained

more than twice that much. The managers have the

flexibility to look throughout the globe and across

the market-cap spectrum; thus, the portfolio currently

holds

28%

of assets in foreign stocks, and its

$23

billion average market cap is in the bottom decile of

the large-growth category. That positioning weighed

on results this year, as U.S. stocks outperformed

foreign equities and large caps trounced small caps.

Nonetheless, the managers boast a strong long-

term record.

Matthews China

MCHFX

This fund lost

4

.

4%

in

2014

, underperforming its

typical China-region peer by nearly

6

percentage

points and marking the third-consecutive calendar

year of below-average results. In

2014

and over the

trailing three years, generally poor stock selection

and minimal exposure to Taiwan weighed on results.

Moreover, a bias toward growing companies has

consistently led to an underweighting in financials

and an overweighting in consumer companies,

which hindered results in

2014

as the former has

rallied and the latter has struggled.

œ

Contact Leo Acheson at

leo.acheson@morningstar.com

Ten Worst-Performing Funds

Fund Name

YTD Cat Rank %

Fairholme

99

GoodHaven

99

Janus Overseas T

99

Longleaf Partners Interna 99

Baron Opportunity Retail

98

Delafield Fund

98

FPA Capital

98

Fairholme Focused Income 98

Artisan Small Cap Value I

97

CGM Focus

97

Ten Best-Performing Funds

Fund Name

YTD Cat Rank %

FPA Perennial

1

Fidelity Capital & Income

1

Meridian Small Cap Growth 1

PRIMECAP Odyssey Aggressi 1

Tweedy, Browne Global Val

1

Vanguard Capital Opportun 1

Vanguard GNMA Inv

1

Vanguard Long-Term Invest 1

Vanguard PRIMECAP Core In 1

Vanguard PRIMECAP Inv

1

Another Strong Year for T. Rowe Price

Capital Appreciation

Leaders & Laggards

|

Leo Acheson